Stay updated on Adjunctive KarXT in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Adjunctive KarXT in Schizophrenia Clinical Trial page.

Latest updates to the Adjunctive KarXT in Schizophrenia Clinical Trial page
- Check8 days agoChange DetectedSponsor name updated from Karuna Therapeutics to Karuna Therapeutics, Inc., a Bristol Myers Squibb company. This aligns the sponsor with current corporate ownership and ensures accurate attribution on the study record.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded: Results Submitted and Revision: v3.5.0; Removed: No Results Posted and Revision: v3.4.3. These changes indicate that results have been submitted and the page revision has been updated.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page's revision label changed from v3.4.2 to v3.4.3. This is a minor metadata update reflecting a new release version.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 in the page history. No substantive study data or record content changes.SummaryDifference0.1%

- Check72 days agoChange DetectedIntroduced a glossary toggle and legends for color-coded changes (green = additions, red = deletions). Updated the revision notice to v3.4.0 and removed the 'No FEAR Act Data' text.SummaryDifference0.6%

Stay in the know with updates to Adjunctive KarXT in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive KarXT in Schizophrenia Clinical Trial page.